HMG-CoA reductase inhibitors improve heart rate variability in patients with a previous myocardial infarction.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Pharmacological Research

• Publication date

  2002-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1006/PHRS.2002.0988PMID 12162949
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heart rate variability after long-term treatment with atorvastatin in hypercholesterolaemic patients with or without coronary artery disease.

  2001cited by this paper
• Marine n-3 Fatty Acids, Wine Intake, and Heart Rate Variability in Patients Referred for Coronary Angiography

  2001cited by this paper
• Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting.

  2000cited by this paper
• Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients.

  2000cited by this paper
• Heart rate variability and plasma lipids in men with and without ischaemic heart disease.

  1999cited by this paper
• Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile.

  1999cited by this paper
• Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men.

  1999cited by this paper
• Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS).

  1998cited by this paper
• Esterified cholesterol accumulation induced by aggregated LDL uptake in human vascular smooth muscle cells is reduced by HMG-CoA reductase inhibitors.

  1998cited by this paper
• Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

  1998cited by this paper
• Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction

  1998cited by this paper
• Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

  1998cited by this paper
• Importance of endothelial function in mediating the benefits of lipid-lowering therapy.

  1998cited by this paper
• Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.

  1998cited by this paper
• Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial.

  1998cited by this paper
• Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators.

  1998cited by this paper
• Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease.

  1997cited by this paper
• Direct vascular effects of HMG-CoA reductase inhibitors.

  1997cited by this paper
• The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

  1996cited by this paper
• Heart rate variability. Standards of measurement, physiological interpretation, and clinical use

  1996cited by this paper
• Distinction between arrhythmic and nonarrhythmic death after acute myocardial infarction based on heart rate variability, signal-averaged electrocardiogram, ventricular arrhythmias and left ventricular ejection fraction.

  1996cited by this paper
• Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

  1996cited by this paper
• Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

  1996cited by this paper
• The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion.

  1995cited by this paper
• Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease.

  1995cited by this paper
• Lipid-lowering interventions in angiographic trials.

  1995cited by this paper
• Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia.

  1994cited by this paper
• Heart rate variability: a measure of cardiac autonomic tone.

  1994cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• Decreased heart rate variability and its association with increased mortality after acute myocardial infarction.

  1987cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper

• Simultaneous quantification of two commonly used anticoagulant drugs and three hypolipidemic drugs in human plasma using gradient high-performance liquid chromatography

  2024cites this paper
• Exploratory multivariate analysis of the effect of fatty fish consumption and medicinal use on heart rate and heart rate variability data

  2015cites this paper
• The effect of statins on sympathetic activity: a meta-analysis

  2015cites this paper
• The Relationship between Serum Lipid Fractions and Heart Rate Variability in Diabetic Patients with Statin Therapy

  2014cites this paper
• Low-Density Lipoprotein-Cholesterol-Induced Endothelial Dysfunction and Oxidative Stress: The Role of Statins

  2014cites this paper
• Statins and the autonomic nervous system.

  2014cites this paper
• Heart rate recovery and heart rate variability are unchanged in patients with coronary artery disease following 12 weeks of high-intensity interval and moderate-intensity endurance exercise training.

  2013cites this paper
• Dansk Nyremedicinsk Forskning

  2012cites this paper
• Statins and the Reduction of Sudden Cardiac Death

  2010cites this paper
• Effects of Lipid-Altering Therapies on Ventricular Arrhythmias and Sudden Cardiac Death

  2009cites this paper
• Potential autonomic nervous system effects of statins in heart failure.

  2008cites this paper
• ДИНАМИКА ПОКАЗАТЕЛЕЙ ВАРИАБЕЛЬНОСТИ РИТМА СЕРДЦА У ПАЦИЕНТОВ С ПАРОКСИЗМАЛЬНОЙ ФОРМОЙ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ ПРИ ЛЕЧЕНИИ АТОРВАСТАТИНОМ

  2008cites this paper
• Short- and long-term effect of simvastatin therapy on the heterogeneity of cardiac repolarization in diabetic patients.

  2008cites this paper
• Effects of statin treatment on serum sex steroids levels and autonomic and erectile function.

  2008cites this paper
• Lipid-lowering therapy with statins, a new approach to antiarrhythmic therapy.

  2007cites this paper
• Simvastatin improves the attenuated heart rate recovery of type 2 diabetics.

  2006cites this paper
• The effect of atorvastatin on heart rate variability and lipoproteins in patients treated with coronary bypass surgery.

  2006cites this paper
• Statins, Ventricular Arrhythmias and Heart Rate Variability in Patients with Implantable Cardioverter Defibrillators and Coronary Heart Disease

  2005cites this paper
• Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure.

  2005cites this paper
• A prospective evaluation of the effect of simvastatin on heart rate variability in non-ischemic cardiomyopathy.

  2005cites this paper
• Hypolipidemic drugs, blood pressure, heart rate, heart rate variability and sympathetic activity

  2004cites this paper
• Statins and Hypertension

  2004cites this paper
• Rosuvastatin Decreases Caveolin-1 and Improves Nitric Oxide–Dependent Heart Rate and Blood Pressure Variability in Apolipoprotein E−/− Mice In Vivo

  2003cites this paper
• Statin therapy restores sympathovagal balance in experimental heart failure.

  2003cites this paper